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Background:  Cancer  is  the  third  leading  cause  of mortality  in  Kenya,  accounting  for 7%  of annual  deaths.  The
Kenyan  Ministry  of Health  (MOH)  is  committed  to reducing  cancer  mortality,  as evidenced  by policies
such  as  the  National  Cancer  Control  Strategy  (2011–2016).  There  are  many  Kenyan  and international
organizations  devoted  to this  task;  however,  coordination  is lacking  among  stakeholders,  resulting  in
inefﬁcient  and overlapping  expenditure  of  resources.
Methods: The  MOH  and  the  NCI  Center  for Global  Health  collaboratively  executed  a two  day  work-
shop  to improve  coordination  among  government,  NGO,  and private  organizations.  Over  80  stakeholders
participated  from  leading  cancer  research  and  control  institutions  in  Kenya  and  the international  sphere.
Findings:  Actionable  recommendations  include:  establishment  of  a  nationally  representative  population-
based  cancer  registry;  enhanced  training  for community  health  workers,  nurses,  researchers,
pathologists,  and  oncology  specialists;  a reconﬁgured  referral  process,  including  leveraging  of existing
resources  to improve  access  to cancer  care;  and  coordinated  community  outreach  and  education.  The
MOH is  in the  process  of forming  a Technical  Working  Group  (TWG)  and  has  elected  a  Board  of Direc-
tors  for  the  newly  established  Kenyan  National  Cancer  Institute  (KNCI),  with both  entities  committed  to
advancing  the  cancer  control  work  of  the MOH.
Interpretation:  This  stakeholder  meeting  enhanced  in-country  networks,  identiﬁed  priority  needs  and
developed actionable  proposals  for coordinated  improvement  of  cancer  research  and  control.  Active,
persistent  follow-up  by  the  TWG,  KNCI,  and  other  partners  will  be needed  to turn  proposals  into  reality
and  ensure  that  partners’  investments  are  integrated  into  larger  cancer  control  efforts  prioritized  by  MOH.
Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://. Introduction
Non-communicable diseases (NCDs) cause more deaths in low-
nd middle-income countries (LMIC) than all infectious causes, a
eality that will be even more pronounced by 2030 [1]. In Kenya, an
stimated 40,000 new cancer cases and 28,000 cancer deaths occur
ach year [2], making cancer the third leading cause of mortality
nd accounting for 7% of all annual deaths [3]. The Kenya Med-
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ical Research Institute (KEMRI) documents that 80% of reported
cases in the country are diagnosed at an advanced stage, leaving
few options for remediation [3]. Late diagnosis, combined with the
lack of and uneven distributions of cancer diagnosis and treatment
facilities, personnel, and equipment, highlight the importance of a
National Cancer Control Program as a fundamental next step for
Kenyan policy.
The Kenyan Government has demonstrated commitment to
reducing cancer mortality, as evidenced by policies such as the
National Cancer Control Strategy (2011–2016) [3] and others [4–7].
Additionally, the Cancer Prevention and Control Act (2012) called
for the establishment of a National Cancer Institute of Kenya (KNCI)
to advise the Cabinet Secretary, collect and analyze research data,
collaborate with partners, disseminate information, and support
treatment facilities and training [8].
D license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table  1
Organizations represented at the Kenya Cancer Research and Control National Stakeholder Meeting.
Organization type Kenya United States
Government – Kenya Ministry of Health
– Mombasa County government
– CDC KEMRI
- US National Cancer Institute (NCI), NIH
-  Fogarty International Center, NIH
- Centers for Disease Control and Prevention (CDC)
Research Institutions - Kenya Medical Research Institute (KEMRI)
-  African Population and Health Research Center
- The Epidemiology of Burkitt Lymphoma in East-African Children
and Minors Project, NCI
Academia - Aga Khan University
- Moi  University
- Moi  University School of Medicine
- University of Nairobi
- Duke University
- Indiana University School of Medicine
- University of Alabama
- University of Maryland
- University of Massachusetts Medical School
- University of North Carolina, Chapel Hill
- University of Washington
Cancer care - Cancer Care Kenya
- The Nairobi Hospital
- Moi  Teaching and Referral Hospital
-  Aga Khan University Hospital
- Kenyatta National Hospital
-  AIC Kijabe Hospital
-  East Africa Public Health Laboratory Networking Project
- Denver Health
NGO  - Academic Model Providing Access to Healthcare (AMPATH)*
- Machakos Women
-  Childhood Cancer Initiative
- Kenya Network of Cancer Organizations
-  Kenya Cancer Association
- Kenya Hospices and Palliative Care Association
-  Women  4 Cancer Early Detection and Treatment
-  KEMRI–FACES (Family AIDS Care and Education Services)*
International - World Health Organization (WHO)
-  International Atomic Energy Agency (IAEA)
-  PATH
- University of Burundi†
*
†
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 Burundi, East Africa.
Many other stakeholders are also involved in cancer work in
enya. The US National Institutes of Health (NIH) and the US Cen-
ers for Disease Control and Prevention (CDC) collectively invested
160.1 M into Kenya’s health sector from 2010 to 2012. Six US NCI-
esignated cancer centers are also partnering with research groups
n Kenya, which include the Academic Model Providing Access to
ealthcare (AMPATH), the Kenya Network of Cancer Organizations
KENCO), and KEMRI. The US President’s Emergency Plan for AIDS
elief (PEPFAR) funding and the AMPATH Oncology and Hematol-
gy Institute have additionally provided support for cervical cancer
creening and treatment program implementation.
Though many domestic and international organizations are
ommitted to reducing cancer mortality in Kenya, a lack of coor-
ination exists among these stakeholders. As a result, inefﬁcient
nd over-expenditure of resources leads to little progress made
n implementation of national cancer policies. The Kenya Cancer
esearch and Control National Stakeholder Meeting provided an
pportunity for these groups to interact and develop coordinated
ction plans toward their shared goal of improved cancer research
nd control in Kenya.
. Methods
To improve coordination among stakeholders, the Kenyan Min-
stry of Health (MOH) and the US National Cancer Institute (NCI)
enter for Global Health (CGH) collaboratively executed a two-
ay in-country workshop to address national cancer control and
esearch priorities. NCI CGH chaired a planning committee of stafffrom the MOH, 6 NCI-designated cancer centers, and the US CDC.
Current challenges were consolidated into 4 central Track themes:
clinical research priorities and capacity building; cancer registries
and pathology; cancer awareness, community engagement and
stigma; and national health delivery infrastructure and access to
care. Each Track was co-chaired by a representative from Kenya
and a US planning committee partner. Co-chairs met weekly or bi-
weekly in the 4 months preceding the meeting to gather necessary
cancer control status information and to plan workshop sessions.
The meeting was  structured to bring all stakeholders face-to-
face to draft a tangible, multi-year action plan. Over 80 entities
were represented, including the Kenyan government, the US gov-
ernment, Kenyan and foreign academic and cancer research and
control institutions, private and faith-based hospitals, and non-
governmental organizations (NGOs) in the health and research
sectors (Table 1). Partners from the International Atomic Energy
Agency (IAEA) and the World Health Organization (WHO) also par-
ticipated.
Sessions were structured as follows: Day 1 included a plenary
session in which hospitals and organizations described the state
of cancer control and care services at their institutions. Then the
4 Track working groups began separate discussions on their spe-
ciﬁc topics and their related action plans. Day  2 continued action
planning in Track groups and included rapid-ﬁre presentations of
these plans to all meeting attendees. The meeting concluded with
sessions on the importance and facilitation of partnerships and
concrete next steps presented by the MOH. Follow-up calls were
planned for 3, 6, 9, and 12 months (Table 2).
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Table  2
Kenya Cancer Research and Control National Stakeholder Meeting recommendations and follow-up.
Track Progress to date Long term goals
Clinical research priorities and
capacity building
• June–September 2015: formation of a cancer research
advisory board; formation of a dedicated training
working group to set national cancer research and
control training priorities and capacity building needs
•  September 2015: ﬁrst cancer research advisory board
meeting
• Communication channel amongst in and out-of-country
researchers
•  Integrate research into the national agenda and establish
a  cancer research advisory board to liaise through KNCI
• Convene panels to assess current programs research
gaps
•  Identify capacity building needs, centralize training
information
•  Conduct grant writing workshops, instruction in
research management
Cancer registries and pathology • April 2015: quality and needs assessment of the current
population based cancer registries (PBCRs), to be
followed by support of PBCR development and capacity
building
•  June 2015–2017: 2 year trial of the CAP electronic forms
and reporting module for gross and microscopic
description and synoptic reporting of cancer specimens
• May  2015–September 2017: pathology resident-driven
training of local hospital personnel in FNA/BMA
collection and processing in select level 5 hospitals
• Strengthen Kenya’s three PBCRs and establish a new
PBCR on the eastern coast (Mombasa)
• Develop hospital-based cancer registries in level 5
hospitals
•  Establish a National Population-based Cancer Registry
Central Data Center, merging data from regional PBCRs
•  Upgrade pathology services to create Centers of
Pathology Excellence in select level 5 hospitals
• Expand pathology training opportunities
Cancer  awareness, community
engagement, and stigma
• August 2014-present: community education working
group
•  May  2015-present: engagement with the American
Cancer Society (ACS) to commence the Knowledge,
Attitude, and Practice (KAP) process with MOH  guidance
•  May  2015-present: desk review in partnership with
ACS: existing Information, Education, and
Communication materials in Kenya
• Coordinate knowledge sharing about community
education efforts
• Engage community leaders and members to identify key
drivers of stigma through KAP studies
• Develop culturally appropriate messages to address
perceptions and knowledge gaps
•  Raise public awareness about cancer prevention and
early detection; reach 60% of the population by 2018
National health delivery
infrastructure and access to care
• April 2015-present: developing cancer management
protocols: priority cancer selection and committee
membership
•  May  2015-present: developing Guidelines for
Establishing a Comprehensive Cancer Center
•  June 2015-present: coordinating dialogue: patient
ﬁnancing, childhood cancer consortium
• Leverage HIV/AIDS infrastructure (referral,
transportation networks) established through PEPFAR
•  Develop curricula for referral systems and training
•  Include essential cancer drugs in the KEMSA drug list
• Support MOH  to establish radiotherapy units, cancer
treatment and palliative centers
• MOH  fund chemotherapy through the National Health
·
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.1. Track 1: Clinical research priorities and capacity building
Co-chaired by Dr. Esther Arthur Ogara (MOH), Dr. Patrick
oehrer (Indiana University Cancer Center) and Dr. Jack Welch
NCI).
Kenya is already a leader among African countries in publish-
ng internationally recognized quality research in areas such as
mmunology [9]. Meeting participants recognized that the country
lso has the opportunity to excel in cancer research, given strong
xisting research institutions and willingness for collaboration.
The ﬁrst step towards development of a domestic cancer
esearch program is to establish a communication channel amongst
n and out-of-country researchers. A Kenyan cancer research web
ortal will be a central resource to track all ongoing efforts, pro-
ide a repository for shared data, locate research gaps, function as
 medium for scientiﬁc discussion, and coordinate future activities.
To make research results relevant to policy makers, a cancer
esearch advisory board will be established, comprised of leaders
rom cancer-related constituencies such as researchers and patient
dvocates. This board will integrate research into the national
genda and will issue advisory statements every six months to the
oard of Directors of the KNCI, which interfaces directly with the
OH to guide national cancer policy.
Stakeholders identiﬁed 4 common and actionable priority can-
ers for clinical research: cervical, breast, prostate, and pediatric. ToInsurance Fund
address these cancers, panels will convene to assess current screen-
ing, prevention and treatment programs, identify research gaps,
and coordinate national research efforts. The resulting evidence
will be published and disease-speciﬁc recommendations made to
the cancer research advisory board.
To adequately fund cancer research in Kenya, stakeholders will
perform and publish a costing analysis to inform policy makers
about the cost of each desired program, fuel advocacy efforts to
engage external funders to complement Kenyan funded initiatives,
and potentially allow lawmakers to codify cancer funding into the
national budget.
As the pool of Kenyan researchers is limited, nationally and
externally sourced grants will be offered to encourage early career
development and retain young researchers in Kenya. Grant writing
workshops and instruction in research management will ensure
that investigators have the resources to perform their work and
to limit loss due to frustration over inadequate funding. These
efforts will link with programs that will increase oncology con-
tent in medical and post-graduate training, and increase training
for oncology sub-specialties and for specialties that support can-
cer research (e.g. radiotechnology and epidemiology). A number
of international partner institutions currently offer research train-
ing programs in Kenya including the CDC Field Epidemiology
Training Programs (FETP), the Integra Initiative, and several pro-
grams offered through the Fogarty International Center (FIC) of the
NIH.
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.2. Track 2: Cancer registries and pathology
Co-chaired by Dr. Shahin Sayad (AKU), Ms.  Ann Korir (KEMRI),
r. Sanford Dawsey (NCI) and Ms.  Annette Galassi (NCI).
Cancer registry and pathology stakeholders prioritized the
trengthening and expansion of Kenya’s three existing population-
ased cancer registries (PBCRs) located in Eldoret, Nairobi, and
isumu. To achieve this goal, case ascertainment in the current
atchment areas must expand and data quality improve to the
0–90% competence level deﬁned as a minimum by the Interna-
ional Agency for Research on Cancer (IARC) [10].
As registries are currently staffed by volunteers or part-time
mployees, full-time workers will be hired to thoroughly collect
ase information. Health facility staff will undergo cancer and can-
er registry training in order to increase awareness among hospital
ecision makers and those who will be referring cases to the reg-
stries.
As current records only capture populations in western Kenya
nd urban Nairobi, Stakeholders also prioritized the establishment
f a new PBCR in the city of Mombasa on Kenya’s eastern coast. The
ew registry will collect data on some of Kenya’s eastern popula-
ion groups, expanding the range and diversity of data available
o researchers and policy makers. MOH  will also encourage the
evelopment of hospital-based cancer registries (HBCRs) in Level 5
ospitals, with the goal of eventually upgrading these to PBCRs.
Finally, stakeholders recommended the establishment of a
ational Population-Based Cancer Registry Central Data Center to
rovide researchers and policy makers a more accurate picture of
he true rates and trends of cancer incidence in Kenya. Funded and
ustained by the MOH  through the KNCI, this center will oversee
he merging of data from the three existing and any future PBCRs.
To improve pathology services in Kenya, stakeholders recom-
ended the upgrading of pathology practice in selected Level 5
ospitals outside of Nairobi, creating regional Centers of Pathology
xcellence. As 50 of Kenya’s 60 pathologists are based in Nairobi,
ost counties retain only a sole pathologist or none at all. As a ﬁrst
tep towards improvement, quality and needs assessments will be
erformed at targeted Level 5 hospitals and individual pathology
mprovement plans developed for each of these centers. In addi-
ion, evidence-based standard operating procedures and tools will
e developed and implemented to achieve standardized specimen
andling, processing, and reporting of major cancers in the selected
ospitals.
At these Centers of Excellence pathology residents will lead
raining of medical ofﬁcers, surgeons, nurses, and technicians in
roper collection and processing of ﬁne needle aspirate and bone
arrow aspirate specimens, to allow more accurate diagnosis and
etter patient care. Stakeholders also planned for the installation
f telepathology systems to link these Centers of Excellence with
he clusters of pathologists working at the University of Nairobi
nd Aga Khan University. This will widen the experience of pathol-
gy resident trainees and will give the Level 5 hospital pathologists
ccess to consultations and continuing medical education (CME).
.3. Track 3: Cancer awareness, community engagement, and
tigma
Co-chaired by Dr. Mary Wangai (MOH), Dr. Natasha Buchanan
CDC), Ms.  Mishka Cira and Dr. Makeda Williams (NCI).
A signiﬁcant barrier to cancer control derives from miscon-
eptions and stigma surrounding cancer etiology, prevention,
creening and treatment. Stakeholders prioritized engaging key
ommunity leaders, developing and testing education tools, and
arrying out additional Knowledge, Attitudes, and Practices (KAP)
tudies to identify existing cultural beliefs, drivers of stigma,
nd existing knowledge of cancer prevention. The KAP studycer Policy 7 (2016) 36–41 39
report will be adapted to target groups including women, men,
community leaders, schools, religious leaders, underserved pop-
ulations, providers, and community health workers. To address
community education on cancer prevention and early detection,
culturally-appropriate Information, Education and Communication
(IEC) materials such as ﬂiers, brochures, advertising messages, and
posters will be developed, translated into local languages, and dis-
seminated through appropriate channels identiﬁed through KAP
study ﬁndings.
On a larger scale, a health education action plan will be created
and health education mapped in various settings such as barazas,
religious gatherings, women’s groups, peer groups, and social
mobilization campaigns through engagement of county health
teams and community-based champions. The number of activities
performed and number of people reached will be assessed on a
quarterly basis and evaluated using a follow-up KAP survey. Stake-
holders aim to raise public awareness about cancer prevention and
early detection, with the goal of reaching 60% of the population by
2018. These efforts will reduce late presentation of cancer cases
which leave Kenyans with palliative care as a sole option.
3.4. Track 4: National health delivery infrastructure and access to
care
Co-chaired by Prof. Nicholas Othieno-Abinya (UoN), Dr.  Linda
Kupfer (FIC) and Ms.  Kalina Duncan (NCI).
Radical devolution has placed the responsibility of healthcare
on the county governments which struggle with a lack of clear
referral systems, treatment protocols, ﬁnancing, and expertise to
diagnose and treat cancers at the county level. For example, Nairobi
is the only place in the country with radiotherapy resources, with
public services centralized at one hospital: Kenyatta National Hos-
pital (KNH). To improve access to care, stakeholders prioritized
greater leveraging of resources and HIV/AIDS infrastructure. Repli-
cating the AMPATH-Oncology model, patients will utilize existing
HIV/AIDS referral and transportation networks to obtain can-
cer treatment [11]. Access to care will further improve through
standardization of protocols, curriculum development for refer-
ral systems, and incorporation of cancers into the current referral
policy.
Stakeholders identiﬁed high treatment costs as a barrier to
healthcare delivery. Patients admitted to KNH currently pay 1,500
Kenya shillings (Ksh) per week per bed, while private hospitals can
charge up to 80,000 Ksh per week. CT scans and MRIs are priced
at 10,000–30,000 Ksh, and chemotherapy treatment can require
30,000 Ksh per course [12]. Stakeholders will negotiate and lobby
for the National Health Insurance Fund (NHIF) to cover chemother-
apy and for the creation of a national cancer fund, to direct resources
towards research that prevents and treats cancer.
To ensure that providers are able to appropriately screen
and refer patients, an assessment of nurses and clinical ofﬁ-
cers will identify those groups in need of supplemental training.
The National Guidelines for Cancer Management (2013) [7] and
developed cancer treatment protocols will be disseminated to dis-
trict hospitals to ensure standardization of procedures. To further
improve treatment quality, essential cancer drugs must also be
included in the Kenya Medical Supplies Agency (KEMSA) drug list as
per the National Guidelines for Cancer Management (2013) [7]. It
is also recommended that KEMSA source cervical cancer screen-
and-treat supplies such as compressed gas-based cryosurgical
equipment for the outpatient treatment of precancerous cervical
lesions. These interventions and others will improve access to can-
cer care for patients for whom the healthcare system is currently
inaccessible.
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. Discussion
.1. Partnerships in cancer control and cancer research
Organizations often work independently from one another
ecause of geographic separation, sector isolation (government,
rivate, NGO, faith-based groups), and objective differentiation
research, training, screening, treatment). The Stakeholders’ Meet-
ng offered cancer organizations the unprecedented opportunity to
oalesce and develop country-level action plans, moving towards
hared goals of cancer control. The Meeting laid the foundation for
he development of effective public-private partnerships to reduce
ancer burden and improve cancer research and care in Kenya.
The partnerships engendered in this meeting can facilitate many
olicy initiatives, including the referral of patients between pri-
ate and public sectors to increase access to cancer treatments.
tilizing the linear accelerator machine at a private hospital to pro-
ide radiotherapy to patients at the overburdened public hospital
ould reduce treatment delays and potentially improve outcomes.
ollaborating on research studies between private and public
rganizations could increase sample sizes, reduce time for study
ompletion, and construct a stronger base for analysis. For instance,
n the months since the meeting, a Kenyan study of triple negative
reast cancer was greatly enhanced through the use of specimens
rovided by private, public and faith-based hospitals [13].
These enormous beneﬁts from partnerships also carry chal-
enges in communication and cooperation. Stakeholder discussions
ighlighted distrust and cultural differences as obstacles to
ffective communication between North American and Kenyan
artners. However, the biggest and most difﬁcult barrier is likely
nancial, as many of the initiatives identiﬁed in the Track action
lans are beyond the means of a single sponsor. This makes the for-
ation of public–private partnerships critical to moving the cancer
ontrol agenda forward. Such partnerships leverage the strengths
nd ﬁnancial assets of each organization and avoid wasteful dupli-
ation of efforts.
.2. Human resources for health
While adequate human resources and infrastructure are neces-
ary for the success of any cancer control initiative, Kenya lacks the
anpower to support quality cancer research, prevention, early
etection, treatment, and end of life care interventions for the
ntire population. Furthermore, oncology-specialization is rare: in
012, Kenya had 6 medical oncologists, 4 radiation oncologists,
nd 3 oncology nurses for a population of 45 million. Relative to
roposed numbers [7], a minimum deﬁcit of 19, 11, and 47 staff
emain, respectively. Despite this large gap, training programs are
eveloping to meet this need. Moi  University (Eldoret, Kenya) and
he University of Toronto (Canada) are collaborating to develop an
ncology nursing curriculum. The Higher National Diploma pro-
ram in Medical Oncology at Moi  University welcomed its inaugural
lass of clinical ofﬁcers in the fall of 2013. Moi  University, Aga Khan
niversity Hospital and the University of Nairobi are also develop-
ng fellowships for medical oncology, incorporating research into
he training program.
The need for additional cancer specialty training for clinicians
nd researchers was a pervasive theme amongst stakeholders. Pri-
rities include medical oncology, radiotherapy, surgical oncology,
ncology nursing, and pathology. Kenyan university coursework
ontent should also include IRB and human subject protec-
ion, epidemiology, biostatistics, and prevention, diagnosis, and
anagement of common cancers at community in-service and pre-
ervice levels. Stakeholders suggested that academic institutions
ead curricula review and mount training programs for medical
pecialists. The KNCI and MOH  will assist by updating pre-servicecer Policy 7 (2016) 36–41
curricula to include research methodology and epidemiology, with
the option of an intercalated degree in research. In-service health
workers will also receive training with the new curricula developed
through this partnership. Increasing the workforce of cancer spe-
cialists and the cancer knowledge of other health system staff and
community health workers will allow a greater number of ordi-
nary people to access education about the basics of cancer and its
prevention and treatment.
4.3. Kenya ministry of health initiatives
MOH  is currently establishing mechanisms to ensure that
the National Cancer Control Strategy (2011–2016) [3], the
outcomes of the Stakeholder Meeting, and governmental and non-
governmental activities are pursued in coordination to minimize
duplication of work and to maximize effectiveness toward achiev-
ing cancer control targets.
Aligning with the Cancer Prevention and Control Act (No. 15 of
2012) [8], MOH  inaugurated the ﬁrst Board of Trustees for the KNCI
in February 2015. The Board is comprised of professionals from
the ﬁelds of medicine, cancer advocacy, cancer research, philan-
thropy, law, ﬁnance, private sector development, and the media.
The KNCI is mandated to advise the Cabinet Secretary on matters
concerning cancer awareness, diagnosis, treatment and rehabilita-
tion. This includes provision for increased public awareness about
cancer, adequate access to cancer diagnosis and treatment, estab-
lishment of vocational training, coordination of cancer registration
and research, and action on environmental and socioeconomic fac-
tors that contribute to cancer prevalence [8].
In order to further advance stakeholder objectives, a Cancer Con-
trol Technical Working Group (CCTWG) has been established since
the Meeting, made up of technical experts working in cancer pre-
vention and control. The CCTWG will serve as the coordinating body
for cancer prevention and control activities and will report to the
non-communicable disease inter-agency coordinating committee
of the MOH  and the technical arm of the KNCI. The MOH  is in the
process of ﬁnalizing the terms of reference and membership of the
CCTWG.
4.4. NCI-supported post-meeting activities
NCI has also contributed to stakeholder coordination efforts
through a short-term in-country consultant to MOH. This consul-
tant supports policy development and coordinates communication
mechanisms to minimize duplication of activities amongst part-
ners. This includes the development of speciﬁc cancer treatment
protocols for selected cancers in Kenya through the efforts of a
multi-sectorial technical working group; the ﬁnalization of can-
cer management guidelines; and the establishment of a review and
revision plan for the National Cancer Control Strategy (2011–2016)
[3].
The College of American Pathologists (CAP) has partnered with
a combination of stakeholders to provide a 2-year trial of the elec-
tronic Forms and Reporting Module (eFRM) for standardized gross
and microscopic description, and synoptic reporting of cancer spec-
imens. Training and implementation of the electronic system will
commence at Aga Khan University and the University of Nairobi in
the fall of 2015. In addition, these universities have collaborated
to develop the Cytology Improvement Project, acquiring experts to
train pathology residents in ﬁne needle aspirate, bone marrow aspi-
rate, and bone marrow trephine biopsy acquisition and processing.
These residents will in turn conduct workshops at targeted Level 5
hospitals to train medical ofﬁcers, surgeons, clinical ofﬁcers, nurses,
and technicians, continuing to support these programs for up to 5
years.
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Multiple stakeholders have additionally formed a community
ducation working group, comprised of representatives from the
S NCI, US CDC, MOH  and civil society. The group has engaged
ith the American Cancer Society (ACS) to commence KAP study
evelopment through MOH  guidance and leadership. The working
roup has supported an ACS desk review of existing Information,
ducation and Communication (IEC) materials in Kenya, in order to
etter understand the current health messages being shared, and to
ssist in integrating the results of the planned KAP studies into dis-
emination efforts. Local and international cancer advocacy groups,
uch as the Kenya Network of Cancer Organizations (KENCO) and
he Women’s Empowerment Cancer Advocacy Network (WE  CAN)
ill also be key partners for raising public awareness and cancer
dvocacy at the community level. To that end, the working group
ill develop a database of local and international cancer advocacy
artners active in Kenya, to serve as a resource for networking,
nformation sharing, and collaboration.
. Conclusion
The Kenya Cancer Research and Control National Stakeholder
eeting enhanced in-country networks, identiﬁed priority needs
nd developed actionable proposals for coordinated improvement
f cancer research and control that align with the priorities set by
he Kenyan MOH  [3]. Active, persistent follow-up by the TWG, KNCI,
nd both Kenyan and international partners will be needed to turn
eveloped proposals into reality and achieve the goals of involved
takeholders. It is the hope that this meeting has served as a catalyst
o accelerate cancer efforts in Kenya, and will serve as a model for
uture country stakeholder meetings, guiding partners towards a
ore uniﬁed approach to cancer research and control.
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